Day: April 19, 2021

PHILADELPHIA, April 19, 2021 (GLOBE NEWSWIRE) — Republic First Bancorp, Inc. (NASDAQ: FRBK), the holding company for Republic Bank, announced that it expects to issue financial results for the first quarter of 2021 on Thursday, April 22, 2021. The Company will hold a conference call to review these results on the same day at 11:00am (EDT). Analyst and Investor Call   Date: April 22, 2021Time: 11:00am (EDT)From the U.S. dial: (888) 466-9845 US Toll Free or  (847) 619-6751 US TollParticipant Pin:  7195 650#   An operator will assist you in joining the call.   Replay Information: Will be available on the Company’s website on the Investor Relations page.   About Republic Bank Republic Bank, a subsidiary of Republic First Bancorp, Inc., is a full-service, state-chartered commercial bank, whose deposits...

Washington, D.C., April 19, 2021 (GLOBE NEWSWIRE) — Advancing the firm’s ongoing mission to pursue and ensure equality within the legal profession, lawyers at Hunton Andrews Kurth LLP contributed 9,000 hours to diversity and inclusion activities and the firm achieved 100% participation in D&I projects from its full-time U.S. lawyers during the firm’s recently ended fiscal year. In April 2020, Hunton Andrews Kurth’s leadership challenged all of its full-time lawyers throughout the United States to participate in activities that advance diversity and inclusion within the firm, the legal profession and the community. Modeled after the firm’s pro bono initiative, which has achieved 100% participation for more than 10 consecutive years, the diversity and inclusion challenge was overwhelmingly successful during the 2021 fiscal year,...

SB 11285 in Combination with Radiation is More Effective than Either as Monotherapy in a Murine Tumor Model SB 11285 is a Second Generation STING Agonist Delivered Intravenously CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., April 19, 2021 (GLOBE NEWSWIRE) — F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with cancer, today announced the publication of a new study, conducted by Yale University and F-star, of its second generation STING agonist, SB 11285, in the current issue of Nature Communications. The study entitled “STING enhances cell death through regulation of reactive oxygen species and DNA damage” demonstrates that systemic administration of a STING agonist in combination with radiation...

MONACO, April 19, 2021 (GLOBE NEWSWIRE) — Navios Maritime Holdings Inc. (“Navios Holdings”) (NYSE:NM) announced today that it will host a conference call on Wednesday, April 21, 2021 at 8:30 am ET, at which time Navios Holdings’ senior management will provide highlights and commentary on earnings results for the fourth quarter and year ended December 31, 2020. The Company will report results for the fourth quarter and year ended December 31, 2020, prior to the conference call. A supplemental slide presentation will be available on the Navios Holdings website at www.navios.com under the “Investors” section by 8:00 am ET on the day of the call. Conference Call details:Call Date/Time: Wednesday, April 21, 2021 at 8:30 am ETCall Title: Navios Holdings Q4 2020 Financial Results Conference CallUS Dial In:...

COURTOIS S.A. La Société COURTOIS SA vous informe que la prochaine Assemblée Générale des actionnaires aura lieu le 27 mai 2021 à 15 h 30 dans les salons de l’Hôtel :« Mercure Saint Georges – Rue Saint Jérôme – 31 000 TOULOUSE » Cette information se trouve sur le site Internet « http://www.courtois-sa.com » sous la rubrique :Espace Actionnaires « Actualités 2021 »et a été transmise à l’AMF le 19 avril 2021.   A Toulouse, le 19 avril 2021 SOCIETE ANONYME AU CAPITAL DE 1 673 940 €Siège Social : 3, rue Mage- BP 48531 – 31685 TOULOUSE CEDEX 6Tél. :05.62.26.73.22 – Télécopie : 05.62.26.74.82Contact : accueil@courtois.frhttp://www.courtois-sa.com540.802 105 R .C.S  TOULOUSE Pièce jointe

Opinion of the Management Board of the Joint-stock company “VALMIERAS STIKLA ŠĶIEDRA” on the offer of mandatory share buy-back of the company and its impact on the public interest On April 13, 2021, the Financial and Capital Market Commission decided to permit Duke I S.à r.l. (hereinafter – the Offeror), the shareholder of VALMIERAS STIKLA ŠĶIEDRA, AS (Registration No.: 40003031676, legal address: Cempu iela 13, Valmiera, LV-4201) (hereinafter – the Company), to issue the mandatory share buy-back offer (hereinafter – the Offer) approving the buy-back price of one share 0.54 EUR. The Management Board of the Company finds the Offer to be compliant with the conditions of the Financial Instruments Market Law. The Management Board positively evaluates the Offer considering the fact that the Offeror intends to continue the...

MILAN, Italy, and FLORHAM PARK, N.J., April 19, 2021 (GLOBE NEWSWIRE) — Conduent Transportation, a unit of business process services and solutions company Conduent Incorporated (Nasdaq: CNDT), today announced the implementation of a new system in Bergamo, Italy, to monitor the maximum number of passengers on buses managed by Azienda Trasporti Bergamo (ATB) and trams managed by its associated company, Tramvie Elettriche Bergamasche (TEB). The system will enable ATB and TEB to easily comply with government regulations in place to deal with the COVID-19 pandemic. The regulations, issued by the Italian Ministry of Transport in response to the pandemic, limit the number of bus and tram passengers to 50 percent of the maximum capacity, as determined by the vehicle’s registration certificate. The automatic passenger counting system allows...

VANCOUVER, British Columbia, April 19, 2021 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, reports that it has received a notice of allowance from the Canadian Intellectual Property Office (CIPO) for its 2015 licensed patent application, No. 2887841 entitled, “Cannabis Drug Detection Device”. The Company has been pursuing this original patent application since its filing on April 16, 2015. It should be noted that a notice of allowance from the CIPO does not constitute a grant of patent. The Company will report on future material developments regarding its “Cannabis Drug Detection Device” patent application with CIPO in due course. Cannabix Technologies is on the forefront in research...